Virtual Reality Exercise Program for People with Type 2 Diabetes
An E-therapist: an Interactive Immersive Virtual Reality Exercise Program for People with Type 2 Diabetes
1 other identifier
interventional
124
1 country
1
Brief Summary
The purpose of this study is to examine the effectiveness of a virtual reality (VR) based rehabilitation protocol for improvement of blood glucose control and exercise compliance of patients. Subjects aged 55-85 diagnosed with Type 2 diabetes will be recruited. A written consent will be obtained from subjects. Subjects recruited will be randomly divided into one of the two groups. The VR group will receive an exercise program conducted in elderly centre or a control group will receive home exercise program. The 12-week exercise program will be conducted three times per week and each session will last for one hour. Assessment that takes about one hour to complete will be carried out at baseline, mid-way (6th week) and after the 12-week exercise training. Assessment items include physical, psychosocial and cognitive function. Also, blood test on HbA1c will be carried out at baseline and at the end of the 12-week training. During this course of research, subjects are strongly advised to stay with their present lifestyle and medication.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 6, 2023
CompletedFirst Posted
Study publicly available on registry
March 31, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 25, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2024
CompletedMarch 13, 2025
March 1, 2023
2.6 years
March 6, 2023
March 11, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Glycated Hemoglobin (HbA1C)
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout exercise program. Blood tests will be performed by a nurse at the community center and HbA1c tests will be conducted by a private medical laboratory.
Baseline
Glycated Hemoglobin (HbA1C)
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout
6 weeks
Glycated Hemoglobin (HbA1C)
HbA1c can be used to evaluate how well-controlled blood sugar has been throughout
12 weeks
Secondary Outcomes (45)
Chair Stand Test
Baseline
Chair Stand Test
6 weeks
Chair Stand Test
12 weeks
Arm Curl Test
Baseline
Arm Curl Test
6 weeks
- +40 more secondary outcomes
Study Arms (2)
Immersive Virtual Reality Exercise (IVRE)
EXPERIMENTALVR exercise training for at least three times a week for 12 consecutive weeks (a total of 36 sessions) guided by the e-therapist: The tailored VR-based exercise program involves aerobic and resistance exercises, and VR games.
Home Exercise
ACTIVE COMPARATORIndividuals randomized to the control group will attend a briefing session prior to the start of the program to complete demographic data collection and physical assessment. They will be given an exercise booklet and guided through a set of home-based exercises (identical training to the intervention group except for VR games) in the briefing session. Stepping exercises will be implemented as a substitution of cycling as an aerobic exercise training at home.
Interventions
The IVRE program will include aerobic exercise, muscle strengthening exercise, balance and flexibility exercise.
Aerobic exercise, muscle strengthening exercise, balance and flexibility exercise at home.
Eligibility Criteria
You may qualify if:
- Individuals aged between 55 and 80 years with a confirmed diagnosis of type 2 diabetes mellitus (T2DM) and an HbA1c of ≥ 6.5% and ≤ 11%.
You may not qualify if:
- Individuals will be excluded if they have a history of any of the following conditions: cardiac arrest, complex dysrhythmias at rest, complicated myocardial infarction or revascularization procedure, presence of congestive failure, presence of angina, signs or symptoms of post-event myocardial ischemia, renal impairment or proteinuria, hepatic impairment, severe gout or hyperuricemia or uncontrolled hypertension, a fall within the last year, musculoskeletal impairment such as inability to walk independently (after stroke or serious arthritis), neurocognitive disorder, or other diseases that limit their ability to engage in physical activities will be excluded. Individuals enrolled in other physical training programs will also be excluded to ensure any true effect of the proposed intervention can be captured.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hong Kong Polytechnic University
Hong Kong, Hong Kong, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessor(s) will be blinded to the allocation of participants throughout the study. The name of the participants and the allocation will be removed from the assessment sheet.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
March 6, 2023
First Posted
March 31, 2023
Study Start
June 1, 2022
Primary Completion
December 25, 2024
Study Completion
December 25, 2024
Last Updated
March 13, 2025
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share
Data will be available upon request.